174 related articles for article (PubMed ID: 37843251)
1. Accuracy of QuantiFERON in active tuberculosis suspects with comorbidities and nontuberculous mycobacterial infection in Northern California.
Lu J; Murugesan K; Senchyna F; Budvytiene I; Banaei N
J Clin Microbiol; 2023 Nov; 61(11):e0077523. PubMed ID: 37843251
[TBL] [Abstract][Full Text] [Related]
2. Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019.
Yang C; Luo X; Fan L; Sha W; Xiao H; Cui H
Front Cell Infect Microbiol; 2020; 10():571230. PubMed ID: 33680977
[TBL] [Abstract][Full Text] [Related]
3. [Evolution of IGRA researches].
Ariga H; Harada N
Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
[TBL] [Abstract][Full Text] [Related]
4. Specificity of QuantiFERON-TB Plus, a New-Generation Interferon Gamma Release Assay.
Siegel SAR; Cavanaugh M; Ku JH; Kawamura LM; Winthrop KL
J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30232132
[TBL] [Abstract][Full Text] [Related]
5. Interferon gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation.
Takwoingi Y; Whitworth H; Rees-Roberts M; Badhan A; Partlett C; Green N; Boakye A; Lambie H; Marongiu L; Jit M; White P; Deeks JJ; Kon OM; Lalvani A
Health Technol Assess; 2019 May; 23(23):1-152. PubMed ID: 31138395
[TBL] [Abstract][Full Text] [Related]
6. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay].
Harada N
Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047
[TBL] [Abstract][Full Text] [Related]
7. A Two-Step Real-Time PCR Method To Identify Mycobacterium tuberculosis Infections and Six Dominant Nontuberculous Mycobacterial Infections from Clinical Specimens.
Park J; Kwak N; Chae JC; Yoon EJ; Jeong SH
Microbiol Spectr; 2023 Aug; 11(4):e0160623. PubMed ID: 37378523
[TBL] [Abstract][Full Text] [Related]
8. Clinical reevaluation of the QuantiFERON TB-2G test as a diagnostic method for differentiating active tuberculosis from nontuberculous mycobacteriosis.
Kobashi Y; Obase Y; Fukuda M; Yoshida K; Miyashita N; Oka M
Clin Infect Dis; 2006 Dec; 43(12):1540-6. PubMed ID: 17109285
[TBL] [Abstract][Full Text] [Related]
9. First clinical evaluation of the QIAreach
Fukushima K; Akagi K; Kondo A; Kubo T; Sakamoto N; Mukae H
Pulmonology; 2022; 28(1):6-12. PubMed ID: 34362702
[TBL] [Abstract][Full Text] [Related]
10. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.
Wang MS; Wang JL; Wang XF
BMC Pulm Med; 2016 Nov; 16(1):163. PubMed ID: 27887611
[TBL] [Abstract][Full Text] [Related]
11. Comparison of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in the Diagnosis of
Xu Y; Yang Q; Zhou J; Zhou F; Hezhang Y; Gao Y; Shao L; Shi J; Ruan Q; Zhang W
Microbiol Spectr; 2022 Apr; 10(2):e0187021. PubMed ID: 35234509
[TBL] [Abstract][Full Text] [Related]
12. The performance of interferon gamma release assays in patients with nontuberculous mycobacterial infection: a systematic review and meta-analysis.
Guan CP; Wu YH; Wang XF; He Y; Zhang YA; Wang MS
Eur J Clin Microbiol Infect Dis; 2023 Oct; 42(10):1251-1262. PubMed ID: 37702955
[TBL] [Abstract][Full Text] [Related]
13. Interferon Gamma Release Assays in Patients with Respiratory Isolates of Non-Tuberculous Mycobacteria - a Preliminary Study.
Augustynowicz-Kopeć E; Siemion-Szcześniak I; Zabost A; Wyrostkiewicz D; Filipczak D; Oniszh K; Gawryluk D; Radzikowska E; Korzybski D; Szturmowicz M
Pol J Microbiol; 2019; 68(1):15-19. PubMed ID: 31050249
[TBL] [Abstract][Full Text] [Related]
14. Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark.
Hermansen TS; Thomsen VØ; Lillebaek T; Ravn P
PLoS One; 2014; 9(4):e93986. PubMed ID: 24705675
[TBL] [Abstract][Full Text] [Related]
15. The use of purified protein derivative mycobacterial skin test antigens in children and adolescents: purified protein derivative skin test results correlated with mycobacterial isolates.
Margileth AM
Pediatr Infect Dis; 1983; 2(3):225-31. PubMed ID: 6408620
[TBL] [Abstract][Full Text] [Related]
16. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
Matsumoto T; Yamazaki T
Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.
Lempp JM; Zajdowicz MJ; Hankinson AL; Toney SR; Keep LW; Mancuso JD; Mazurek GH
PLoS One; 2017; 12(5):e0177752. PubMed ID: 28545136
[TBL] [Abstract][Full Text] [Related]
18. Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution?
Pollock NR; Campos-Neto A; Kashino S; Napolitano D; Behar SM; Shin D; Sloutsky A; Joshi S; Guillet J; Wong M; Nardell E
Infect Control Hosp Epidemiol; 2008 Sep; 29(9):878-86. PubMed ID: 18713053
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of a tuberculosis-specific gamma interferon release assay in military personnel with a positive tuberculin skin test.
van Brummelen SE; Bauwens AM; Schlösser NJ; Arend SM
Clin Vaccine Immunol; 2010 Jun; 17(6):937-43. PubMed ID: 20375241
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
